Skip to content

Effects of Roux-en-Y Gastric Bypass on Gastro-intestinal Hormone Secretion and Brain Responses Food Pictures

Dynamic Effect of Gastrointestinal Hormones on Cerebral Mechanisms Involved in Brain Perception of Food Pictures After Bariatric Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02160379
Enrollment
31
Registered
2014-06-10
Start date
2011-01-31
Completion date
2012-03-31
Last updated
2014-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

roux-en-Y-gastric bypass, brain responses to food, gastrointestinal hormones, bile acids

Brief summary

This is a cross-sectional study enrolling * 11 weight-stable, formerly obese female patients 1-5 years after Roux-en-Y gastric Bypass (RYGB) * 11 age- and weight-matched female subjects * 10 normal weight (Body Mass Index 19-25 kg/m2) subjects The following measurements will be performed in each participants in basal conditions (after an overnight fast) and after ingestion of a standard meal * electroencephalographic recordings of visually evoked potential after presentation of food- or non-food pictures * plasma concentration of metabolites (glucose, fatty acids), glucoregulatory hormones (insulin, glucagon), gastro-intestinal hormones (Gastric Inhibitory Polypeptide (GIP), Glucagon-like Peptide-1 (GLP1), ghrelin,Cholecystokinin (CCK), and bile acids Aims of this observational study are * to evaluate the effects of RYGB on brain perception of food related visual stimulation * to search for relationships between RYGB effects on brain responses and gastro-intestinal hormone secretion

Interventions

OTHERstandard test meal

Sponsors

University of Lausanne
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* good apparent health * gender: female * age 18-50 * non-smoker

Exclusion criteria

* diabetes or antidiabetic medication * consumption of more than 50g alcohol per week * vegetarian or any special diet

Design outcomes

Primary

MeasureTime frameDescription
Changes of visually-evoked EEG potentials after ingestion of a mealbasal, 120 min postprandial and 240 postprandialRecording and analysis of visual evoked potentials (VEPs) while patients categorize photographs of foods and non-food kitchen utensils

Secondary

MeasureTime frameDescription
changes in plasma triglyceride concentration after ingestion of a mealbasal, 90 min postprandial and 180 postprandialMeasurement of triglyceride concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal)
Changes in plasma glucoincretins (GLP1 and GIP) concentrations after ingestion of a mealbasal, 90 min postprandial and 180 postprandialMeasurement of GLP1 and GIP concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal)
Changes in plasma cholecystokinin concentrations after ingestion of a mealbasal, 90 min postprandial and 180 postprandialMeasurement of cholecystokinin concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal)
Changes in plasma bile acids concentrations after ingestion of a mealbasal, 90 min postprandial and 180 postprandialMeasurement of bile acids concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal)
changes in plasma glucoregulatory status after ingestion of a mealbasal, 90 min postprandial and 180 postprandialMeasurement of glucose, insulin, glucagon and non-esterified fatty acid concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026